Stanford stem cell product, delayed for more than a decade, to be tested again

STANFORD — In the 1990s, Stanford’s Irv Weissman created a unique way to grow and deliver blood stem cells to desperate patients with aggressive cancers, boosting survival rates. But then the discovery itself died — a victim of the heartbreaking …

[Read the full article here]

Comments are closed.